ELTOCLAV 625 combines the proven power of Amoxycillin with the beta-lactamase inhibitor Clavulanate Potassium, ensuring reliable coverage for infections caused by resistant organisms.
Key product inputs are consolidated below. Fields without information are intentionally left blank for your regulatory or marketing team to update.